Aurobindo, Hetero, and Vivimed Class Action Settlements in Virginia
Aurobindo, Hetero, and Vivimed class action settlements that covered Virginia residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Virginia residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Virginia Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Virginia
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Virginia residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed pharmaceutical companies have legal options under both federal regulations and Virginia's Consumer Protection Act. These manufacturers distributed valsartan, losartan, and irbesartan medications containing NDMA and other carcinogenic impurities throughout Virginia's healthcare system from 2012-2018. Virginia's Consumer Protection Act provides additional protections beyond federal law, allowing residents to pursue deceptive trade practice claims against pharmaceutical companies that fail to disclose safety issues. Aurobindo maintains significant distribution networks serving Virginia pharmacies, while Hetero and Vivimed products reached Virginia consumers through major pharmacy chains including CVS and Walgreens. Virginia residents must file class action claims within the statute of limitations, typically two years from discovery of the contamination. The state's proximity to Washington D.C. means many cases are consolidated in federal court for efficiency. Virginia's strong consumer protection framework and established pharmaceutical liability precedents create favorable conditions for residents seeking compensation through the $15.2 million valsartan, losartan, and irbesartan settlement covering these three manufacturers.
Aurobindo, Hetero, and Vivimed Settlements in Virginia: FAQs
Are Virginia residents eligible for the Aurobindo, Hetero, and Vivimed blood pressure medication settlement?
Yes, Virginia residents who took contaminated valsartan, losartan, or irbesartan from these manufacturers between 2012-2018 can file claims in the $15.2 million settlement. Virginia's inclusion in the nationwide class action ensures residents receive the same compensation opportunities as other affected states.
Does Virginia's Consumer Protection Act provide additional rights beyond the federal settlement?
Virginia's Consumer Protection Act allows residents to pursue separate state law claims for deceptive trade practices if the settlement doesn't fully compensate their damages. This gives Virginia residents potential additional legal remedies beyond the federal class action settlement.
How long do Virginia residents have to file claims against these pharmaceutical companies?
Virginia residents typically have two years from discovering the contamination to file claims, though the specific settlement may have different deadlines. The federal settlement deadline takes precedence for class action participants, so residents should file promptly to preserve their rights.
Tips for Virginia Residents Filing Aurobindo, Hetero, and Vivimed Claims
Virginia residents filing Aurobindo, Hetero, and Vivimed claims should gather prescription records from 2012-2018 showing specific manufacturers and lot numbers. Contact your pharmacy for detailed medication history, as many chains like CVS keep digital records. Virginia's Consumer Protection Act may provide additional state law remedies if federal settlements prove insufficient. File claims promptly to meet settlement deadlines, and consider consulting Virginia attorneys familiar with pharmaceutical liability cases. Document any cancer diagnoses or health issues potentially linked to NDMA exposure. Virginia residents benefit from strong consumer protection laws that complement federal pharmaceutical regulations.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
